Cosmo Pharmaceuticals NV
SIX:COPN

Watchlist Manager
Cosmo Pharmaceuticals NV Logo
Cosmo Pharmaceuticals NV
SIX:COPN
Watchlist
Price: 65 CHF Market Closed
Market Cap: 1B CHF
Have any thoughts about
Cosmo Pharmaceuticals NV?
Write Note

Gross Margin
Cosmo Pharmaceuticals NV

77%
Current
59%
Average
48.3%
Industry

Gross Margin is the amount of money a company retains after incurring the direct costs associated with producing the goods it sells and the services it provides. The higher the gross margin, the more capital a company retains, which it can then use to pay other costs or satisfy debt obligations.

Gross Margin
77%
=
Gross Profit
145.7m
/
Revenue
189.3m

Gross Margin Across Competitors

Country IE
Market Cap 1B CHF
Gross Margin
77%
Country JP
Market Cap 776 550.9T JPY
Gross Margin
-3%
Country US
Market Cap 761.8B USD
Gross Margin
81%
Country UK
Market Cap 440.4B GBP
Gross Margin
56%
Country DK
Market Cap 3.3T DKK
Gross Margin
85%
Country US
Market Cap 368.4B USD
Gross Margin
69%
Country US
Market Cap 250.9B USD
Gross Margin
77%
Country CH
Market Cap 208.8B CHF
Gross Margin
73%
Country CH
Market Cap 181.2B CHF
Gross Margin
75%
Country UK
Market Cap 158.6B GBP
Gross Margin
82%
Country IE
Market Cap 155B USD
Gross Margin
68%

Profitability Report

View the profitability report to see the full profitability analysis for Cosmo Pharmaceuticals NV.

See Also

Discover More
What is Gross Margin?

Gross Margin is the amount of money a company retains after incurring the direct costs associated with producing the goods it sells and the services it provides. The higher the gross margin, the more capital a company retains, which it can then use to pay other costs or satisfy debt obligations.

Gross Margin
77%
=
Gross Profit
145.7m
/
Revenue
189.3m
What is the Gross Margin of Cosmo Pharmaceuticals NV?

Based on Cosmo Pharmaceuticals NV's most recent financial statements, the company has Gross Margin of 77%.